Media Release
Hound Labs Names Steve Lewis as Chief Executive Officer
Steve Lewis joins as the Company shifts focus to growth and scaling commercialization
FREMONT, Calif. – Oct. 1, 2023 – Hound Labs, Inc., developers of advanced breath testing technologies, announces the appointment of Steve Lewis as its new President and Chief Executive Officer. Lewis is succeeding the Company’s Co-Founder, Dr. Mike Lynn, who will assume a new role as the Chairman of the Board of Directors.
Steve Lewis brings more than 30 years of experience scaling and leading innovative technology companies. Known for his operational expertise and cultivating industry-leading, high-growth companies, his career includes leadership positions at All Covered, Teneros, Pharmanex, and Booz Allen Hamilton. Most recently, Steve served as CEO of Dataprise, a premier provider of managed IT, cybersecurity, and cloud solutions, where he led the company through significant growth during the COVID-19 pandemic.
“I’m excited to step into the role of CEO at Hound Labs,” said Lewis. “Hound Labs is at the forefront of cannabis breath testing. I look forward to building on that foundation to not only meet the market demand for the HOUND® CANNABIS BREATHALYZER1 but also to create a best-in-class service experience for our customers.”
“This transition marks an important moment as Hound Labs moves into a new phase focused on accelerating commercialization and growth,” said Dr. Mike Lynn. “Steve is a seasoned CEO with decades of relevant experience scaling companies with a variety of advanced and complex products. He will have an immediate impact on the Company.”
About Hound Labs
Hound Labs, Inc. develops advanced breath testing technologies to address leading public health and safety issues. The Company’s flagship product is the HOUND® CANNABIS BREATHALYZER, an ultra-sensitive, analytical test that identifies THC molecules in breath. Breath testing introduces the drug testing industry’s shortest cannabis detection window, giving employers a practical and objective solution to detect and deter recent use. By limiting cannabis detection to use occurring before or during the workday, test results empower employers to maintain safe workplaces, improve hiring and retention efforts, and maintain fairness in the workforce. Founded in 2014, Hound Labs is headquartered in Fremont, California. Benchmark, EEC, Icon Ventures, Intrinsic Capital Partners, NFP Ventures, Tuatara Capital, and individual investors have funded the Company. Learn more at HoundLabs.com and follow us on LinkedIn @HoundLabs, Inc.
1 The HOUND® CANNABIS BREATHALYZER is intended to detect recent marijuana use. It does not measure whether, or how much, a person is impaired. It is intended solely for use in employment, law enforcement, and insurance settings. It should not be used for any medical or therapeutic purposes, or for any Federal drug testing programs, such as programs run by the Substance Abuse and Mental Health Services Administration (SAMHSA), the Department of Transportation (DOT), and the U.S. military.
